Search company, investor...

Founded Year



Reverse Merger | IPO

Total Raised


Market Cap


Stock Price


About Sema4

Sema4 is a patient-centered health intelligence company that operates in the healthcare sector. The company's main services involve the use of artificial intelligence and machine learning to analyze clinical and genomic data, with the aim of building dynamic models of human health and defining optimal, individualized health trajectories. Sema4 primarily sells to the healthcare industry. It was founded in 2017 and is based in Stamford, Connecticut.

Headquarters Location

333 Ludlow Street North Tower, 8th floor

Stamford, Connecticut, 06902,

United States

800-298 6470



Research containing Sema4

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Sema4 in 2 CB Insights research briefs, most recently on Dec 20, 2022.

Expert Collections containing Sema4

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sema4 is included in 4 Expert Collections, including Digital Health 50.


Digital Health 50

150 items

The winners of the second annual CB Insights Digital Health 150.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Precision Medicine Tech Market Map

160 items

This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.


Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

Sema4 Patents

Sema4 has filed 1 patent.

The 3 most popular patent topics include:

  • electronic health records
  • health informatics
  • kernel methods for machine learning
patents chart

Application Date

Grant Date


Related Topics



Electronic health records, Health informatics, Machine learning, Standards for electronic health records, Kernel methods for machine learning


Application Date


Grant Date


Related Topics

Electronic health records, Health informatics, Machine learning, Standards for electronic health records, Kernel methods for machine learning



Latest Sema4 News

Sema4 Assumes Management and Control of Melody Capital Partners LP

Mar 17, 2023

NEW YORK--(BUSINESS WIRE)--Sema4, Inc. (“Semaphore”), announced today that its wholly-owned subsidiary and SEC registered investment adviser, House Hanover LLC has formally accepted court appointment as the Liquidation Trustee of the parent company that controls Melody Capital Partners, a role that it assumed in August of 2022 pursuant to an agreement with the founding partners, and that was confirmed by an order from the Delaware Chancery Court (C.A. No. 2022-0008-PAF) on February 10, 2023. Me

Sema4 Frequently Asked Questions (FAQ)

  • When was Sema4 founded?

    Sema4 was founded in 2017.

  • Where is Sema4's headquarters?

    Sema4's headquarters is located at 333 Ludlow Street, Stamford.

  • What is Sema4's latest funding round?

    Sema4's latest funding round is Reverse Merger.

  • How much did Sema4 raise?

    Sema4 raised a total of $241M.

  • Who are the investors of Sema4?

    Investors of Sema4 include BlackRock, Deerfield Management, T. Rowe Price, Casdin Capital, CM Life Sciences and 15 more.

  • Who are Sema4's competitors?

    Competitors of Sema4 include Tempus and 6 more.


Compare Sema4 to Competitors

xCures Logo

xCures is a health technology company that has created an AI- and expert-supported Perpetual Clinical Trial platform that continuously learns from all patients, on all treatments, all the time. It provides patients, and their physicians, with individualized treatment options and facilitates access via reimbursement, clinical trials and expanded-access support. It was founded in 2018 and is based in Los Altos, California.

Tempus Logo

Tempus is a company focused on precision medicine, operating within the healthcare and artificial intelligence sectors. The company offers services that utilize artificial intelligence to provide physicians with real-time, data-driven decisions for personalized patient care and targeted therapies. It also facilitates the discovery, development, and delivery of optimized therapeutic options for patients. It was founded in 2015 and is based in Chicago, Illinois.

Helix Logo

Helix works as a population genomics company operating in the healthcare and life sciences sectors. The company provides solutions that enable health systems, public health organizations, and life science companies to integrate genomic data into patient care and public health decision-making. Its primary customers are health systems, public health entities, and life science companies. It was founded in 2015 and is based in San Mateo, California.

nference Logo

nference is a science-first software company that focuses on transforming unstructured data from electronic medical records (EMR) into powerful software solutions in the healthcare and life sciences industry. The company's main services include the development of software products that enable the synthesis of biomedical information, the creation of AI-enabled solutions for healthcare, and the provision of tools that unlock insights from structured and unstructured patient records. nference primarily sells to the healthcare ecosystem, with a focus on medical centers and biopharmaceutical companies. It was founded in 2013 and is based in Cambridge, Massachusetts.

Syapse Logo

Syapse develops software for aggregating and structuring biomedical data. It combines data intelligence, insight analytics and applied experience through healthcare organizations looking to transform patients’ lives using real-world evidence. The company was founded in 2008 and is based in San Francisco, California.

Owkin Logo

Owkin operates as an artificial intelligence (AI)-based biotechnology company. It utilizes AI to enhance the process of finding suitable treatments for patients. The company's main services include the use of AI to identify new treatments, accelerate clinical trials, and build diagnostic tools. It enables researchers in hospitals, universities, and the biopharmaceutical industry to understand how drug efficacy varies for the improvement of drug development. Its services primarily cater to the biopharmaceutical and academic research sectors. It was founded in 2016 and is based in New York, New York.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.